Variant report
Variant | esv14604 |
---|---|
Chromosome Location | chr4:56609458-56610582 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:56481534..56484408-chr4:56607415..56610057,2 | K562 | blood: | |
2 | chr4:56596053..56598450-chr4:56609132..56610849,2 | K562 | blood: | |
3 | chr4:56600328..56605093-chr4:56606071..56610406,4 | K562 | blood: | |
4 | chr4:56609301..56611255-chr4:56614835..56616393,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4391102 | chr4:56609472-56609473 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs4129570 | chr4:56609483-56609484 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs570716045 | chr4:56609522-56609523 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556550979 | chr4:56609536-56609537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs386674594 | chr4:56609540-56609541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537357025 | chr4:56609555-56609556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73238316 | chr4:56609560-56609561 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs71664300 | chr4:56609641-56609642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78476981 | chr4:56609656-56609657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs71192042 | chr4:56609657-56609658 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200378003 | chr4:56609659-56609660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs77865067 | chr4:56609688-56609689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs373137039 | chr4:56609698-56609699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138726732 | chr4:56609719-56609720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544382785 | chr4:56609735-56609736 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4391103 | chr4:56609736-56609737 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs74376034 | chr4:56609797-56609798 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187692998 | chr4:56609806-56609807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114554338 | chr4:56609817-56609818 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563859344 | chr4:56609866-56609867 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10031105 | chr4:56609872-56609873 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs549595063 | chr4:56609873-56609874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192279747 | chr4:56609875-56609876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528229011 | chr4:56609905-56609906 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551361329 | chr4:56609920-56609921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112391608 | chr4:56609926-56609927 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141182100 | chr4:56609993-56609994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184071822 | chr4:56610072-56610073 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371547459 | chr4:56610103-56610104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537294922 | chr4:56610107-56610108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556982341 | chr4:56610109-56610110 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567589035 | chr4:56610133-56610134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187240332 | chr4:56610143-56610144 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553163514 | chr4:56610152-56610153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572193985 | chr4:56610165-56610166 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563014130 | chr4:56610192-56610193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541144854 | chr4:56610252-56610253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs10003051 | chr4:56610309-56610310 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs28628774 | chr4:56610342-56610343 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs544054206 | chr4:56610351-56610352 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374688175 | chr4:56610361-56610362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs397971037 | chr4:56610367-56610368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563818602 | chr4:56610399-56610400 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529639281 | chr4:56610451-56610452 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542836799 | chr4:56610461-56610462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560003828 | chr4:56610468-56610469 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528165218 | chr4:56610540-56610541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574164409 | chr4:56610551-56610552 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538563300 | chr4:56610563-56610564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Glioblastoma | 17504929 | CNVD |
Glioblastoma | 16823502 | CNVD |
Melanoma | 16908931 | CNVD |
Glioblastoma | 20031968 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Gastrointestinal stromal cancer | 17438095 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Breast cancer | 21785460 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:56608800-56609600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr4:56609000-56609600 | Enhancers | Fetal Stomach | stomach |
3 | chr4:56609200-56609600 | Enhancers | Fetal Muscle Trunk | muscle |
4 | chr4:56609200-56609600 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr4:56609400-56610200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr4:56609400-56613800 | Weak transcription | K562 | blood |
7 | chr4:56610000-56610800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr4:56610200-56611000 | Enhancers | Stomach Mucosa | stomach |